EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
Euroimmun worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

Euroimmun branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

New addition to our dengue test portfolio: Highest specificity for your diagnostics.

Currently, dengue fever poses the greatest challenge in terms of arbovirus infections. With over 14 million cases reported worldwide in 2024, this is the largest ever recorded epidemic of vector-borne ...

Circulating calprotectin – a new promising inflammation parameter

The evaluation of the inflammatory status is crucial for the assessment of disease activity and therapy response in systemic autoimmune rheumatic diseases such as rheumatoid arthritis, systemic ...

Arboviruses: global threat and local reality

Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases worldwide. According to the World Health Organization (WHO), over 5.6 ...

Seoul virus: When pet rats become a risk

Anyone who has got a pet rat at home knows how intelligent and adaptable these animals are. And they are becoming increasingly popular as pets. However, as with all animals in human care, there is a ...

United expertise for ChLIA diagnostics – An interview with Euroimmun

The integration of Immunodiagnostic Systems (IDS) products into the Euroimmun portfolio has created a unique and broad menu of speciality testing solutions. Our combined chemiluminescence immunoassay ...

More lab digitalisation – EUROLabOffice hits 1000 installations milestone

This milestone is much more than just a number: Every single installation stands for a laboratory that decided to leave manual processes behind and to opt for a solution that combines efficiency, ...

New patterns in ANA diagnostics

Recently, three new fluorescence patterns were added to the classification tree of the International Consensus on Antinuclear Antibody Patterns (ICAP)1.

1 www.anapatterns.org

Anti-VGLUT2 autoantibodies identified in neurological and multisystem diseases

Vesicular glutamate transporter 2 (VGLUT2) has been identified as a novel target antigen of autoantibodies in patients with neurological disorders, frequently accompanied by comorbidities with ...

HAND IN HAND FOR POWERFUL ENDOCRINOLOGY – Unique automated chemiluminescence assays for the assessment of sex-hormone imbalances, combining quality and progress

The sex hormones in the human body work together like a complex clockwork. They control not only the development of the female and male sexual characteristics such as the vagina, ovaries and breasts ...

EU approves Alzheimer’s drug – APOE genotype decisive for access to therapy

On 15th April 2025, the European Commission authorised lecanemab (monoclonal anti-amyloid (beta) antibody; trade name: Leqembi from Eisai and Biogen) in the European Union to treat early Alzheimer’s ...

Page 1 of 12.

Back to top